AQP4 and Parkinson disease: Genetic depletion of AQP4 in mice has been shown to elicit a substantial reduction of the clearance of proteins like amyloid β and phosphorylated tau, thus contributing to their accumulation and deposition in the brain, proposed key steps in the pathogenesis of Alzheimer’s and Parkinson’s diseases, respectively (17, 18).